Article2022
Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial
John W. Eikelboom, Jackie Bosch, Stuart J. Connolly, Jessica Tyrwitt, Keith A.A. Fox, Eva Muehlhofer, Christoph Neumann, Christoph Tasto, Shrikant I. Bangdiwala, Rafael Díaz, Marco Alings, Gilles R. Dagenais, Darryl P. Leong, Eva Lonn, Álvaro Avezum, Leopoldo Soares Piegas, Petr Widimský, Alexander Parkhomenko, Deepak L. Bhatt, Kelley R. Branch, Jeffrey L. Probstfield, Patricio López‐Jaramillo, Lars Rydén, Nana Pogosova, Katalin Keltai, Matyàs Keltai, Georg Ertl, Stefan Störk, Antonio L Dans, Fernando Laņas, Yan Liang, Jun Zhu, Christian Torp‐Pedersen, ,
Discussion(0)
No comments yet. Be the first to comment.